CHROMONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS

Details for Australian Patent Application No. 2003253150 (hide)

Owner WARNER-LAMBERT COMPANY LLC

Inventors ORTWINE, Daniel, Fred

Pub. Number AU-A-2003253150

PCT Number PCT/IB03/03541

PCT Pub. Number WO2004/014880

Priority 60/403,094 13.08.02 US

Filing date 4 August 2003

Wipo publication date 25 February 2004

International Classifications

C07D 265/22 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 031/536 - ortho- or peri-condensed with carbocyclic ring systems

A61K 031/352 - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 311/22 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Event Publications

30 October 2003 Complete Application Filed

  Priority application(s): 60/403,094 13.08.02 US

8 April 2004 Application Open to Public Inspection

  Published as AU-A-2003253150

28 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003253151-A METHOD OF CYCLIC MAGNETIC RESONANCE IMAGING

2003253149-3,4-DIHYDROQUINOLIN-2-ONE, 5,6-FUSED OXAZIN-3-ONE, AND 5,6-FUSED THIAZIN-3-ONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS